Management Team and Consultants
Our organization is backed by a highly skilled and committed management team, renowned for its expertise in ophthalmic devices and corporate innovation. Each member brings a wealth of experience and a proven track record that drives our mission forward.
Leadership
Theresa Kramer, MD, MBA
Founder, President, Chairman, CEO & CMO
A retired Professor of Ophthalmology and Pathology, Dr. Kramer has dedicated over 30 years to clinical and surgical academic ophthalmology. Her extensive experience as a serial entrepreneur in medical ophthalmic devices equips her with unique insights into the industry.
Robin Du Bois
VP of Product Development, Prototype Engineer, and Primary Inventor
Robin spearheads product innovation and development, translating visionary concepts into tangible prototypes.
William Eric Sponsel, MD
Specialist in Eye Circulation and Glaucoma
Dr. Sponsel brings essential knowledge in the complexities of ocular circulation and glaucoma management.
Chuck Pritchard
Sales and Marketing
Chuck develops and implements marketing strategies that effectively position our products within the competitive landscape.
Rhonda Grebe
Co-Inventor, Clinical Liaison
Rhonda bridges the gap between clinical practices and product development, ensuring alignment with healthcare provider needs.
Scientific Advisors
R. Doyle Stulting, MD, PhD
Specialization: Regulation and Cornea
Role: Dr. Stulting provides strategic guidance on regulatory matters and corneal health.
William Eric Sponsel, MD
Specialization: Eye Circulation and Glaucoma
Role: Dr. Sponsel offers insights into advancements in eye circulation and glaucoma treatment.
Post-Funding Corporate Board Members
Theresa Kramer, MD, MBA
Stephanie Harrington, MS
Consultants
Legal Corporate
Eugene Indyk and Wilson Sonsini Goodrich & Rosati
Regulatory Support
Matrix Medical, Inc. & Corcoran Group
Reimbursement Strategy
Matrix Medical, Inc. & Corcoran Group
Economic Research
Center for Value-Based Medicine
Contract Manufacturing
LaunchPort
With this experienced team and strong advisory support, we are well-positioned to navigate the challenges of the ophthalmic device market and advance ocular health solutions.